Market Update: Shijiazhuang Yiling Pharma Holds Steady Amidst a Quiet Trading Session
On Thursday, 22 October 2026, the shares of Shijiazhuang Yiling Pharma (002603.SZ) experienced a neutral trading day, closing at exactly the same price they opened at in the 24‑hour period ending at 01:17 AM Central Europe. The stock settled at CNY 15.30, reflecting a flat 0 % movement for the day.
Trading Dynamics
- Shares Outstanding: 1.70 billion
- Market Capitalisation: CNY 25.60 billion
- 24‑Hour Volume: CNY 155.7 million
- Price‑to‑Earnings Ratio (P/E): (not provided; focus on price actions)
The recent 24‑hour trading volume indicates a modest level of liquidity, consistent with the company’s steady performance. The flat daily change comes after a slight decline of 1.6 % since the close of last month, signalling a period of consolidation rather than volatility.
Technical Overview
- Simple Moving Average (SMA, 200 days): CNY 15.90
- 52‑Week High: CNY 21.58 (recorded on 14 November 2025)
- 52‑Week Low: CNY 14.22 (recorded on 29 June 2026)
The current price sits just below the 200‑day SMA, suggesting a mild bearish tilt over the medium term. However, the proximity to the 52‑week low indicates that the stock remains within a tight price range, potentially primed for a rebound if upward pressure materialises.
Peer Comparison
| Stock | Ticker | Current Price | Market Cap | P/E |
|---|---|---|---|---|
| Do‑Fluoride New Materials | 002407.SZ | CNY 25.20 | CNY 4.20 bn | 44.13 |
| Shenzhen MTC | 002429.SZ | CNY 6.76 | CNY 30.60 bn | 29.11 |
| Shandong Xinchao Energy | 600777.SS | CNY 4.46 | CNY 30.50 bn | 51.22 |
| Zhejiang Shuanghuan Drivel | 002472.SZ | CNY 38.72 | CNY 30.70 bn | 25.81 |
| Guolian Minsheng Securities | 1456.HK | HKD 3.36 | HKD 35.90 bn | 8.23 |
While Yiling Pharma’s peers largely remained flat, Guolian Minsheng Securities experienced a modest decline of 2.14 %, highlighting a sector‑wide tendency toward caution during this trading window.
Company Snapshot
Shijiazhuang Yiling Pharmaceutical Co., Ltd. is a Chinese health‑care company headquartered in Shijiazhuang. Specialising in the development, manufacturing, and marketing of Chinese patent medicines, its product portfolio spans anti‑cold remedies, cardiovascular and cerebrovascular drugs, and health‑drinks. Listed on the Shenzhen Stock Exchange, the company conducted its initial public offering on 28 July 2011. Investors and analysts can access further corporate information via the company’s website at www.yiling.cn .
Outlook
With a stable trading day and a price positioned near the 200‑day moving average, Shijiazhuang Yiling Pharma appears poised for a period of consolidation. Market participants will likely monitor the stock’s movement relative to its 52‑week high and low, as well as any forthcoming earnings releases or regulatory announcements that could sway investor sentiment.
